Equity Method Investments (Tables)

12 Months Ended

Oct. 31, 2021

Equity Method Investments and Joint Ventures [Abstract]

The difference between the sale date carrying value of the Company's investment in H3C and its proportionate share of the net assets fair value of H3C, created a basis difference of $2.5 billion, which was allocated as follows:


	In millions
Equity method goodwill	$	1,674
Intangible assets	749
In-process research and development	188
Deferred tax liabilities	(152)
Other	75
Basis difference	$	2,534

The Company amortizes the basis difference over the estimated useful lives of the assets that gave rise to this difference. The weighted-average life of the H3C intangible assets is five years and is being amortized using the straight-line method. As of October 31, 2021 and 2020, the Company determined that no impairment of its equity method investments existed.

Earnings from equity interest

The Company recorded earnings from equity interests of $180 million, $67 million and $20 million in fiscal 2021, 2020 and 2019, respectively, in the Consolidated Statements of Earnings, the components of which are as follows:


	For the fiscal years ended October 31,
	2021		2020		2019
	In millions
Earnings from equity interests, net of taxes(1)	$	292	$	211	$	167
Basis difference amortization	(109)		(145)		(152)
Elimination of profit on intra-entity sales adjustment	(3)		1		5
Earnings from equity interests	$	180	$	67	$	20

(1) In fiscal 2021, earnings from equity interests, net of taxes included $260 million from H3C and $32 million from other venture investments.